AUM
$276.4M
Estimated Dry Powder
Not publicly reported
Fund Size (Latest)
GBS BioVentures III
$115.9M
Estimated Cheque Size
$329K-$3.3M
Stages
- Seed
- Series A
- Series B
Fund Details
Year Established
1996
HQ
Level 5,71 Collins Street, Melbourne, Victoria, 3000, Australia, Australasia
HQ Phone
-
About
GBS Venture Partners (GBS) is a life science venture capital group resulting from a November 2002 management buyout of Rothschild Bioscience Managers Limited from NM Rothschild & Sons (Aust) Ltd. GBS invests in and adds value to unlisted high growth companies involved in innovative technologies. GBS Venture Partners invests in both private and public companies across all stages of company development.
HQ Map
No mappable locations available.